Intrathecal lactate dehydrogenase A inhibitors FX11 and oxamate alleviate chronic constriction injury-induced nociceptive sensitization through neuroinflammation and angiogenesis
Hao-Jung Cheng, Nan-Fu Chen, Wu-Fu Chen, Zong-Sheng Wu, Yu-Yo Sun, Wei-Nung Teng, Fu-Wei Su, Chun-Sung Sung, Zhi-Hong Wen · 2024
Read Intrathecal lactate dehydrogenase A inhibitors FX11 and oxamate alleviate chronic constriction injury-induced nociceptive sensitization through neuroinflammation and angiogenesis by Hao-Jung Cheng, Nan-Fu Chen, Wu-Fu Chen, Zong-Sheng Wu, Yu-Yo Sun, Wei-Nung Teng, Fu-Wei Su, Chun-Sung Sung, Zhi-Hong Wen (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11590346.txt.
Description
Hao-Jung Cheng and eight co-authors test, in a 2024 rat study, whether blocking a sugar-burning enzyme in the spine can ease nerve pain. Nerve injury pain involves inflammation and a surge in glycolysis, the cell's sugar pathway, and few good treatments exist. The enzyme in the spotlight, LDHA, sits at the heart of that pathway and its overdrive feeds both inflammation and pain signals.
Rats with a squeezed nerve got one of two LDHA blockers into the spinal fluid. Both drugs dialled down the injury's rise in the enzyme and softened the animals' pain sensitivity. Inflammation, the polarising of immune cells in the spine, and new vessel growth all eased too. The drugs act on a signalling axis that links the two processes. The authors name LDHA a candidate target.
Catalog record
| CREATOR | Hao-Jung Cheng, Nan-Fu Chen, Wu-Fu Chen, Zong-Sheng Wu, Yu-Yo Sun, Wei-Nung Teng, Fu-Wei Su, Chun-Sung Sung, Zhi-Hong Wen |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 65 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |